Health CanadaGeneral Alert
Archived - Anti-TNFa Therapy: ENBREL (etanercept), HUMIRA (adalimumab), and REMI...
Published: January 18, 2006Recall ID: 24402Category: generalCountry: Canada
Product Description & Identification
Archived - Anti-TNFa Therapy: ENBREL (etanercept), HUMIRA (adalimumab), and REMICADE (infliximab) - Advisories, Warnings and Recalls for the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24402 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/archived-anti-tnfa-therapy-enbrel-etanercept-humira-adalimumab-and-remicade-infliximab |
| Title | Archived - Anti-TNFa Therapy: ENBREL (etanercept), HUMIRA (adalimumab), and REMICADE (infliximab) - Advisories, Warnings and Recalls for the Public |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2006-01-18 |
| Organization | Marketed health products |